Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.
Dwight H Owen1, Navneet Singh2, Nofisat Ismaila3
1Ohio State University, Columbus, OH.
Living guidelines offer rapidly evolving clinical practice recommendations. These guidelines are updated regularly by expert panels to reflect the latest scientific evidence, ensuring current patient care standards.
Area of Science:
- Clinical Practice Guidelines
- Evidence-Based Medicine
- Oncology
Background:
- Clinical practice guidelines require frequent updates due to rapidly evolving evidence.
- The American Society of Clinical Oncology (ASCO) has developed a methodology for living guidelines.
Purpose of the Study:
- To describe the development and methodology of ASCO Living Guidelines.
- To outline the process for systematic literature review and regular updates.
Main Methods:
- Living guidelines are developed for rapidly evolving topic areas.
- A standing expert panel systematically reviews health literature on a continuous basis.
- Updates are published regularly.
Main Results:
- ASCO Living Guidelines are updated on a regular schedule.
- The guidelines adhere to the ASCO Conflict of Interest Policy.
- Updates are available at https://ascopubs.org/nsclc-da-living-guideline.
Conclusions:
- Living guidelines provide a framework for dynamic clinical practice recommendations.
- These guidelines aim to keep clinical practice aligned with the latest evidence.
- Independent professional judgment and patient variation remain crucial in clinical decision-making.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...